These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10151016)

  • 21. Role of exercise testing in relationship to coronary artery bypass surgery and percutaneous transluminal coronary angioplasty.
    Weiner DA; Chaitman BR
    Cardiology; 1986; 73(4-5):242-58. PubMed ID: 2944582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
    Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
    Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant restenosis after primary successful excimer laser coronary angioplasty.
    Buchwald A; Werner G; Unterberg C; Voth A; Wiegand V
    Clin Cardiol; 1990 Jun; 13(6):397-400. PubMed ID: 2344700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can restenosis after coronary angioplasty be predicted from clinical variables?
    Weintraub WS; Kosinski AS; Brown CL; King SB
    J Am Coll Cardiol; 1993 Jan; 21(1):6-14. PubMed ID: 8417077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
    Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
    Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy.
    Casanova R; Varani E; Balducelli M; Patroncini A; Fabbri M; Maresta A
    J Invasive Cardiol; 1994; 6(1):1-6. PubMed ID: 10146699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.
    Weintraub WS; Ghazzal ZM; Douglas JS; Liberman HA; Morris DC; Cohen CL; King SB
    Circulation; 1993 Mar; 87(3):831-40. PubMed ID: 8443903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excimer laser coronary angioplasty of aorto-ostial stenoses. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients.
    Eigler NL; Weinstock B; Douglas JS; Goldenberg T; Hartzler G; Holmes D; Leon M; Margolis J; Nobuyoshi M; O'Neill W
    Circulation; 1993 Nov; 88(5 Pt 1):2049-57. PubMed ID: 8222098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events.
    Benchimol D; Dubroca B; Dufourq P; Benchimol H; Couffinhal T; Dartigues JF; Bonnet J
    Int J Cardiol; 1997 Jul; 60(2):201-11. PubMed ID: 9226292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
    Serruys PW; van Hout B; Bonnier H; Legrand V; Garcia E; Macaya C; Sousa E; van der Giessen W; Colombo A; Seabra-Gomes R; Kiemeneij F; Ruygrok P; Ormiston J; Emanuelsson H; Fajadet J; Haude M; Klugmann S; Morel MA
    Lancet; 1998 Aug; 352(9129):673-81. PubMed ID: 9728982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
    Bourassa MG; Lespérance J; Eastwood C; Schwartz L; Côté G; Kazim F; Hudon G
    J Am Coll Cardiol; 1991 Aug; 18(2):368-76. PubMed ID: 1856404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale.
    Lablanche JM; McFadden EP; Meneveau N; Lusson JR; Bertrand B; Metzger JP; Legrand V; Grollier G; Macaya C; de Bruyne B; Vahanian A; Grentzinger A; Masquet C; Wolf JE; Tobelem G; Fontecave S; Vacheron A; d'Azemar P; Bertrand ME
    Circulation; 1997 Nov; 96(10):3396-402. PubMed ID: 9396433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.